{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:55:42Z","timestamp":1790978142694,"version":"4.1.0"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["ATVB"],"published-print":{"date-parts":[[2002,1]]},"abstract":"<jats:p>\n            Previous in vitro experiments have shown that hyperhomocysteinemia leads to oxidative inactivation of nitric oxide, in part by inhibiting the expression of cellular glutathione peroxidase (GPx-1). To elucidate the role of intracellular redox status on homocysteine-induced endothelial dysfunction and oxidant stress, heterozygous cystathionine \u03b2-synthase\u2013deficient (CBS\n            <jats:sup>\u2212\/+<\/jats:sup>\n            ) and wild-type (CBS\n            <jats:sup>+\/+<\/jats:sup>\n            ) mice were treated with the cysteine donor\n            <jats:sc>l<\/jats:sc>\n            -2-oxothiazolidine-4-carboxylic acid (OTC). CBS\n            <jats:sup>\u2212\/+<\/jats:sup>\n            mice had significantly lower GPx-1 activity compared with their CBS\n            <jats:sup>+\/+<\/jats:sup>\n            littermates, and OTC treatment led to a modest increase in tissue GPx-1 activity and significant increases in total thiols and in reduced glutathione levels in both CBS\n            <jats:sup>+\/+<\/jats:sup>\n            and CBS\n            <jats:sup>\u2212\/+<\/jats:sup>\n            mice. Superfusion of the mesentery with \u03b2-methacholine or bradykinin produced dose-dependent vasodilation of mesenteric arterioles in CBS\n            <jats:sup>+\/+<\/jats:sup>\n            mice and in CBS\n            <jats:sup>+\/+<\/jats:sup>\n            mice treated with OTC. In contrast, mesenteric arterioles from CBS\n            <jats:sup>\u2212\/+<\/jats:sup>\n            mice manifested dose-dependent vasoconstriction in response to both agonists. OTC treatment of CBS\n            <jats:sup>\u2212\/+<\/jats:sup>\n            mice restored normal microvascular vasodilator reactivity to \u03b2-methacholine and bradykinin. These findings demonstrate that mild hyperhomocysteinemia leads to endothelial dysfunction in association with decreased bioavailable nitric oxide. Increasing the cellular thiol and reduced glutathione pools and increasing GPx-1 activity restores endothelial function. These findings emphasize the importance of intracellular redox balance for nitric oxide bioactivity and endothelial function.\n          <\/jats:p>","DOI":"10.1161\/hq1201.100456","type":"journal-article","created":{"date-parts":[[2002,7,28]],"date-time":"2002-07-28T23:16:47Z","timestamp":1027898207000},"page":"34-41","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":124,"title":["Cellular Redox State and Endothelial Dysfunction in Mildly Hyperhomocysteinemic Cystathionine \u03b2-Synthase\u2013Deficient Mice"],"prefix":"10.1161","volume":"22","author":[{"given":"Norbert","family":"Weiss","sequence":"first","affiliation":[{"name":"From the Whitaker Cardiovascular Institute, Evans Department of Medicine (N.W., S.H., Y.-Y.Z., J.L.), and the Departments of Pharmacology (C.B.) and Pathology (A.C.), Boston University School of Medicine, Boston, Mass. N.W. is currently at the Medizinische Poliklinik Innenstadt, Ludwig-Maximilians-Universita\u0308t, Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Heydrick","sequence":"additional","affiliation":[{"name":"From the Whitaker Cardiovascular Institute, Evans Department of Medicine (N.W., S.H., Y.-Y.Z., J.L.), and the Departments of Pharmacology (C.B.) and Pathology (A.C.), Boston University School of Medicine, Boston, Mass. N.W. is currently at the Medizinische Poliklinik Innenstadt, Ludwig-Maximilians-Universita\u0308t, Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Yi","family":"Zhang","sequence":"additional","affiliation":[{"name":"From the Whitaker Cardiovascular Institute, Evans Department of Medicine (N.W., S.H., Y.-Y.Z., J.L.), and the Departments of Pharmacology (C.B.) and Pathology (A.C.), Boston University School of Medicine, Boston, Mass. N.W. is currently at the Medizinische Poliklinik Innenstadt, Ludwig-Maximilians-Universita\u0308t, Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlene","family":"Bierl","sequence":"additional","affiliation":[{"name":"From the Whitaker Cardiovascular Institute, Evans Department of Medicine (N.W., S.H., Y.-Y.Z., J.L.), and the Departments of Pharmacology (C.B.) and Pathology (A.C.), Boston University School of Medicine, Boston, Mass. N.W. is currently at the Medizinische Poliklinik Innenstadt, Ludwig-Maximilians-Universita\u0308t, Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre\u0301","family":"Cap","sequence":"additional","affiliation":[{"name":"From the Whitaker Cardiovascular Institute, Evans Department of Medicine (N.W., S.H., Y.-Y.Z., J.L.), and the Departments of Pharmacology (C.B.) and Pathology (A.C.), Boston University School of Medicine, Boston, Mass. N.W. is currently at the Medizinische Poliklinik Innenstadt, Ludwig-Maximilians-Universita\u0308t, Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Loscalzo","sequence":"additional","affiliation":[{"name":"From the Whitaker Cardiovascular Institute, Evans Department of Medicine (N.W., S.H., Y.-Y.Z., J.L.), and the Departments of Pharmacology (C.B.) and Pathology (A.C.), Boston University School of Medicine, Boston, Mass. N.W. is currently at the Medizinische Poliklinik Innenstadt, Ludwig-Maximilians-Universita\u0308t, Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_1_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03530130055028"},{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.99.1.178"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/72.2.324"},{"key":"e_1_3_3_4_2","first-page":"21","volume":"163","year":"2000","unstructured":"Booth GL, Wang EE. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events: the Canadian Task Force on Preventive Health Care. Can Med Assoc J. 2000; 163: 21\u201329.","journal-title":"Can Med Assoc J"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/heart.83.2.127"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V104891"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199707243370403"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00256.x"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0741-5214(99)70345-9"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)03032-2"},{"key":"e_1_3_3_11_2","first-page":"566","volume":"80","year":"1998","unstructured":"Eichinger S, Stumpflen A, Hirschl M, Bialonczyk C, Herkner K, Stain M, Schneider B, Pabinger I, Lechner K, Kyrle PA. Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism. Thromb Haemost. 1998; 80: 566\u2013569.","journal-title":"Thromb Haemost"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/atvb.18.12.1895"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118771"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI8342"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.2000.279.4.C970"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.98.18.1848"},{"key":"e_1_3_3_17_2","first-page":"1288","volume":"351","year":"1998","unstructured":"Hanratty CG, McAuley DF, McGurk C. Homocysteine and endothelial vascular function. Lancet. 1998; 351: 1288\u20131289.","journal-title":"Lancet"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.99.9.1156"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.101.5.485"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.96.8.2542"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.95.5.1119"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.27.17012"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.2000.279.4.F671"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118776"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)61082-8"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/320454a0"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.1998.274.6.R1704"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112442"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(00)01278-3"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.3.959.415k20_959_967"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.2.238"},{"key":"e_1_3_3_32_2","unstructured":"Floh\u00e9 L. The selenoprotein glutathione peroxidase.In: Dolphin D Poulson R Avramovic O eds. Glutathione: Chemical Biochemical and Medical Aspects. New York NY: John Wiley & Sons Inc; 1989: 644\u2013731."},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.44.27812"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.5.1585"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/41.7.991"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(84)05015-1"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(76)90527-3"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(90)90208-Q"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.26.3.397"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5849(99)00177-X"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.79.20.6246"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.78.2.936"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.74.1.8261584"},{"key":"e_1_3_3_44_2","first-page":"331","volume":"257","year":"1991","unstructured":"Porta P, Aebi S, Summer K, Lauterburg BH. L-2-oxothiazolidine-4-carboxylic acid, a cysteine prodrug: pharmacokinetics and effects on thiols in plasma and lymphocytes in human. J Pharmacol Exp Ther. 1991; 257: 331\u2013334.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI1155"},{"key":"e_1_3_3_46_2","first-page":"263","volume":"43","year":"1992","unstructured":"Shivakumar BR, Ravindranath V. Selective modulation of glutathione in mouse brain regions and its effect on acrylamide-induced neurotoxicity. Biochem Pharmacol. 1992; 43: 263\u2013269.","journal-title":"Biochem Pharmacol"},{"key":"e_1_3_3_47_2","first-page":"341","volume":"237","year":"1986","unstructured":"Hazelton GA, Hjelle JJ, Klaassen CD. Effects of cysteine pro-drugs on acetaminophen-induced hepatotoxicity. J Pharmacol Exp Ther. 1986; 237: 341\u2013349.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_3_48_2","first-page":"49","volume":"61","year":"1988","unstructured":"Moslen MT, Harper BL, Roy D. Effects of a cysteine precursor, L-2-oxothiazolidine-carboxylate, nutritional status, and sex on tissue glutathione and hepatic GSH-utilizing enzymes of CD-1 mice. Res Commun Chem Pathol Pharmacol. 1988; 61: 49\u201363.","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5849(97)00231-1"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(90)90503-X"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(93)90267-O"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)31573-9"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.97.10.953"},{"key":"e_1_3_3_54_2","first-page":"H862","volume":"265","year":"1993","unstructured":"Gaboury J, Woodman RC, Granger DN, Reinhardt P, Kubes P. Nitric oxide prevents leukocyte adherence: role of superoxide. Am J Physiol. 1993; 265: H862\u2013H867.","journal-title":"Am J Physiol"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1161\/atvb.15.10.1652"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(94)90229-1"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1999.276.6.H1943"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00041a023"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1995.2579"}],"container-title":["Arteriosclerosis, Thrombosis, and Vascular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/hq1201.100456","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T02:20:49Z","timestamp":1715653249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/hq1201.100456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["10.1161\/hq1201.100456"],"URL":"https:\/\/doi.org\/10.1161\/hq1201.100456","relation":{},"ISSN":["1079-5642","1524-4636"],"issn-type":[{"value":"1079-5642","type":"print"},{"value":"1524-4636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,1]]},"assertion":[{"value":"2002-01-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}